DR REDDYS LABORATORIES LTD (RDY)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 03-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Annual

0 1.5B 3B 4.5B FY21: 2.6B FY22: 2.8B FY23: 3B FY24: 3.4B FY25: 3.8B FY21 FY22 FY23 FY24 FY25

Gross Profit Annual

0 800M 1.6B 2.4B FY21: 1.4B FY22: 1.5B FY23: 1.7B FY24: 2B FY25: 2.2B FY21 FY22 FY23 FY24 FY25

Operating Income Annual

0 300M 600M 900M FY21: 332M FY22: 389M FY23: 695M FY24: 813M FY25: 842M FY21 FY22 FY23 FY24 FY25

Net Income Annual

0 250M 500M 750M FY21: 236M FY22: 311M FY23: 548M FY24: 668M FY25: 671M FY21 FY22 FY23 FY24 FY25

Cost of Revenue Annual

0 600M 1.2B 1.8B FY21: 1.2B FY22: 1.3B FY23: 1.3B FY24: 1.4B FY25: 1.6B FY21 FY22 FY23 FY24 FY25

Operating Cash Flow Annual

0 250M 500M 750M FY21: 488M FY22: 370M FY23: 716M FY24: 545M FY25: 545M FY21 FY22 FY23 FY24 FY25

Free Cash Flow Annual

0 200M 400M 600M FY21: 355M FY22: 177M FY23: 578M FY24: 348M FY25: 223M FY21 FY22 FY23 FY24 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 300M 600M 900M FY21: 166.3M FY22: 166.3M FY23: 831.9M FY24: 833.5M FY25: 834.2M FY21 FY22 FY23 FY24 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.